Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Reduced P2X receptor levels are associated with antidepressant effect in the learned helplessness model

Texto completo
Autor(es):
Ribeiro, Deidiane Elisa [1, 2, 3] ; Casarotto, Plinio C. [4] ; Staquini, Laura [1] ; Pinto e Silva, Maria Augusta [5] ; Biojone, Caroline [4] ; Wegener, Gregers [2] ; Joca, Samia [5, 6]
Número total de Autores: 7
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, Ribeirao Preto - Brazil
[2] Aarhus Univ, Dept Clin Med, Translat Neuropsychiat Unit, Aarhus - Denmark
[3] Univ Sao Paulo, Chem Inst, Dept Biochem, Sao Paulo - Brazil
[4] Univ Helsinki, Neurosci Ctr HILife, Helsinki - Finland
[5] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Phys & Chem, Ribeirao Preto - Brazil
[6] Aarhus Univ, AIAS, Aarhus - Denmark
Número total de Afiliações: 6
Tipo de documento: Artigo Científico
Fonte: PeerJ; v. 7, OCT 21 2019.
Citações Web of Science: 0
Resumo

Purinergic receptors, especially P2RX, are associated to the severity of symptoms in patients suffering from depressive and bipolar disorders, and genetic deletion or pharmacological blockade of P2RX7 induces antidepressant-like effect in preclinical models. However, there is scarce evidence about the alterations in P2RX7 or P2RX4 levels and in behavioral consequences induced by previous exposure to stress, a major risk factor for depression in humans. In the present study, we evaluated the effect of imipramine (IMI) on P2RX7 and P2RX4 levels in dorsal and ventral hippocampus as well as in the frontal cortex of rats submitted to the pretest session of learned helplessness (LH) paradigm. Repeated, but not acute administration of IMI (15 mg/kg ip) reduced the levels of both P2RX7 and P2RX4 in the ventral, but not in dorsal hippocampus or frontal cortex. In addition, we tested the effect of P2RX7/ P2RX4 antagonist brilliant blue G (BBG: 25 or 50 mg/kg ip) on the LH paradigm. We observed that repeated (7 days) but not acute (1 day) treatment with BBG (50 mg) reduced the number of failures to escape the shocks in the test session, a parameter mimicked by the same regimen of IMI treatment. Taken together, our data indicates that pharmacological blockade or decrease in the expression of P2RX7 is associated to the antidepressant-like behavior observed in the LH paradigm after repeated drug administration. (AU)

Processo FAPESP: 13/01737-7 - Envolvimento do sistema purinérgico na mediação de respostas comportamentais induzidas pelo estresse e no mecanismo de ação de drogas antidepressivas
Beneficiário:Deidiane Elisa Ribeiro
Linha de fomento: Bolsas no Brasil - Doutorado